IM Cannabis (IMCC) Interest & Investment Income (2020 - 2025)
IM Cannabis (IMCC) recorded quarterly Interest & Investment Income of $2.3 million in Q3 2025, up 54.72% quarter-over-quarter from $1.5 million in Q2 2025, and up 537.0% on a YoY basis from $362861.4 in Q3 2024.
IM Cannabis (IMCC) Interest & Investment Income (2020 - 2025) Analysis & Trends
IM Cannabis' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $2.3 million for Q3 2025.
- In Q3 2025, Interest & Investment Income rose 537.0% year-over-year to $2.3 million; the TTM figure through Sep 2025 stood at $2.3 million (up 537.0% YoY), while the FY2025 annual figure was $2.5 million, up 52.35% from the prior year.
- Interest & Investment Income was $2.3 million for Q3 2025 at IM Cannabis, up from $1.5 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $17.2 million in Q3 2021 to a low of -$10389.6 in Q1 2024.
- Historically, Interest & Investment Income has averaged $4.2 million across 5 years, with a median of $2.4 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income slumped 100.4% in 2024, then jumped 5738.02% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $17.2 million in 2021, then slumped by 72.08% to $4.8 million in 2022, then sank by 46.06% to $2.6 million in 2023, then plunged by 85.97% to $362861.4 in 2024, then surged by 537.0% to $2.3 million in 2025.
- The last three Interest & Investment Income figures came in at $2.3 million (Q3 2025), $1.5 million (Q2 2025), and $362861.4 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | IM Cannabis | 46,600.63 | -738,753.90 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Sep 30, 2024 | 362,861.44 |
| Jun 30, 2024 | 25,589.92 |
| Mar 31, 2024 | -10,389.58 |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 2.61 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 2.28 Mn |
| Sep 30, 2021 | 17.17 Mn |
| Jun 30, 2021 | 10.93 Mn |
| Mar 31, 2021 | 5.71 Mn |
| Sep 30, 2020 | 890,002.47 |
| Jun 30, 2020 | 307,954.09 |
| Mar 31, 2020 | 167,080.39 |